Fenofibrate Delays the Need for Dialysis and Reduces Cardiovascular Risk Among Patients With Advanced CKD

MLA

Chih-Hsiang Chang, et al. “Fenofibrate Delays the Need for Dialysis and Reduces Cardiovascular Risk Among Patients With Advanced CKD.” The Journal of Clinical Endocrinology & Metabolism, vol. 106, Mar. 2021, pp. 1594–605. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8d5a284d2bd40ad589f84376ac2e2310&authtype=sso&custid=ns315887.

APA

Chih-Hsiang Chang, Ming-Shyan Lin, Ching-Chung Hsiao, Pei-Chun Fan, Hsiang-Hao Hsu, Cheng-Chia Lee, Ya-Chung Tian, Kun-Hua Tu, Chao-Yu Chen, & Chieh-Li Yen. (2021). Fenofibrate Delays the Need for Dialysis and Reduces Cardiovascular Risk Among Patients With Advanced CKD. The Journal of Clinical Endocrinology & Metabolism, 106, 1594–1605.

Chicago

Chih-Hsiang Chang, Ming-Shyan Lin, Ching-Chung Hsiao, Pei-Chun Fan, Hsiang-Hao Hsu, Cheng-Chia Lee, Ya-Chung Tian, Kun-Hua Tu, Chao-Yu Chen, and Chieh-Li Yen. 2021. “Fenofibrate Delays the Need for Dialysis and Reduces Cardiovascular Risk Among Patients With Advanced CKD.” The Journal of Clinical Endocrinology & Metabolism 106 (March): 1594–1605. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8d5a284d2bd40ad589f84376ac2e2310&authtype=sso&custid=ns315887.